Cargando…

Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis

INTRODUCTION: The presence of liver cirrhosis can have a major impact on pharmacodynamics and pharmacokinetics, but guidance for prescribing is lacking. OBJECTIVE: The aim of this study is to provide an overview of evidence-based recommendations developed for the safe use of drugs in liver cirrhosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weersink, Rianne A., Bouma, Margriet, Burger, David M., Drenth, Joost P. H., Harkes-Idzinga, S. Froukje, Hunfeld, Nicole G. M., Metselaar, Herold J., Monster-Simons, Margje H., Taxis, Katja, Borgsteede, Sander D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966501/ https://www.ncbi.nlm.nih.gov/pubmed/29330714 http://dx.doi.org/10.1007/s40264-017-0635-x

Ejemplares similares

Safe use of proton pump inhibitors in patients with cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion
por: Weersink, Rianne A, et al.
Publicado: (2016)

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study
por: Weersink, Rianne A., et al.
Publicado: (2018)

Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment
por: Weersink, Rianne A., et al.
Publicado: (2019)

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available
por: Weersink, Rianne A., et al.
Publicado: (2019)

Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
por: Weersink, Rianne Antoinet, et al.
Publicado: (2022)

Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients
por: Weersink, Rianne A., et al.
Publicado: (2020)

Medication-Related Problems in Liver Transplant Recipients in the Outpatient Setting: A Dutch Cohort Study
por: Mulder, Midas B., et al.
Publicado: (2021)

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe
por: Koomen, Jeroen V., et al.
Publicado: (2021)

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
por: van Tongeren, Justine M. Z., et al.
Publicado: (2020)

Preventing dispensing errors by alerting for drug confusions in the pharmacy information system—A survey of users
por: Campmans, Zizi, et al.
Publicado: (2018)

Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study
por: Mulder, Midas B., et al.
Publicado: (2022)

Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008
por: Kuiper, Edith MM, et al.
Publicado: (2010)

Improving Medication‐Related Outcomes in Chronic Liver Disease
por: Hayward, Kelly L., et al.
Publicado: (2020)

Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
por: Weersink, Rianne A., et al.
Publicado: (2021)

Screening for abnormal glycosylation in a cohort of adult liver disease patients
por: Jansen, Jos C., et al.
Publicado: (2020)

Barriers and Facilitators of Conducting Medication Reviews in Nursing Home Residents: A Qualitative Study
por: Wouters, Hans, et al.
Publicado: (2019)

Michael Manns winner of the 2022 UEG Lifetime Achievement Award
por: Drenth, Joost P. H.
Publicado: (2022)

Safe Use of POEM in a Patient With Decompensated Cirrhosis and Severe Achalasia
por: Loh, Rebecca, et al.
Publicado: (2023)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

A cost–benefit analysis of hospital-wide medication reviews: a period prevalence study
por: Wilkes, Sarah, et al.
Publicado: (2021)

Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination
por: van Dijk, Marleen, et al.
Publicado: (2020)

UEG journal's editorial team
por: Drenth, Joost P. H., et al.
Publicado: (2022)

Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?
por: Kang, Sin Jae, et al.
Publicado: (2013)

Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR(16)) questionnaire in patients with schizophrenia
por: Lako, Irene M, et al.
Publicado: (2014)

Dose-Escalating (50–500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial
por: Burger, Jordy P. W., et al.
Publicado: (2022)

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
por: Yang, Hayang, et al.
Publicado: (2017)

Pharmacokinetic similarity demonstrated after crushing of the elbasvir/grazoprevir fixed-dose combination tablet for HCV infection
por: Pijnenburg, Daniëlle W M, et al.
Publicado: (2020)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
por: Laschtowitz, Alena, et al.
Publicado: (2021)

Advances in safe insulin infusions
por: Massoomi, Fred, et al.
Publicado: (2021)

Standard MRI May Not Predict Specific Acute Anterior Cruciate Ligament Rupture Characteristics
por: Hoogeslag, Roy A.G., et al.
Publicado: (2021)

Pneumonitis as A Consequence of (Peg)Interferon-Ribavirin Combination Therapy for Hepatitis C: a Review of the Literature
por: Slavenburg, Serena, et al.
Publicado: (2009)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Feeling safe or falling through the cracks—Patients’ experiences of healthcare in cirrhosis illness: A qualitative study
por: Hjorth, Maria, et al.
Publicado: (2023)

Spleen Thickness Plus Platelets Can Effectively and Safely Screen for High-Risk Varices in Cirrhosis Patients
por: Zhang, Fengbin, et al.
Publicado: (2023)

The impact of CYP2D6 mediated drug–drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine
por: Bahar, Muh. Akbar, et al.
Publicado: (2018)

Calculation of Average Mutual Information (AMI) and False-Nearest Neighbors (FNN) for the Estimation of Embedding Parameters of Multidimensional Time Series in Matlab
por: Wallot, Sebastian, et al.
Publicado: (2018)

Management of portal hypertension and ascites in polycystic liver disease
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
por: Smolders, Elise J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hk82hs7ttli201b4i68afebai9